TrialClinical cancer research : an official journal of the American Association for Cancer Research2018

Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors.

Daniel D Von Hoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.